{"id":1,"date":"2025-02-24T15:09:00","date_gmt":"2025-02-24T14:09:00","guid":{"rendered":"http:\/\/aplusa.local\/?p=1"},"modified":"2026-02-03T17:12:17","modified_gmt":"2026-02-03T16:12:17","slug":"social-media-impact-of-the-66th-ash-annual-meeting-exposition-2024","status":"publish","type":"post","link":"https:\/\/www.aplusaresearch.com\/fr\/perspectives\/social-media-impact-of-the-66th-ash-annual-meeting-exposition-2024\/","title":{"rendered":"Impact des m\u00e9dias sociaux sur la 66e r\u00e9union annuelle et exposition de l'ASH 2024"},"content":{"rendered":"

La r\u00e9union annuelle et l'exposition 2024 de l'ASH ont eu lieu du 7 au 10 d\u00e9cembre 2024 \u00e0 San Diego, aux \u00c9tats-Unis.<\/p>\n\n\n\n

Cette ann\u00e9e, l'\u00e9v\u00e9nement s'est d\u00e9roul\u00e9 principalement en personne, avec des retransmissions virtuelles.<\/p>\n\n\n\n

Cette analyse des m\u00e9dias sociaux nous permettra d'\u00e9valuer l'impact du congr\u00e8s en ligne.<\/p>\n\n\n\n

Champ d'application<\/h2>\n\n\n\n

L'analyse porte sur les mentions provenant du monde entier*.<\/p>\n\n\n\n

Il y a eu un total de 10K mentions de HCP enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute du 30 novembre 2024 au 17 d\u00e9cembre 2024 (une semaine avant et une semaine apr\u00e8s la conf\u00e9rence).<\/p>\n\n\n\n

Toutes les mentions proviennent de X.<\/p>\n\n\n\n

Au total, 1,2K auteurs uniques ont \u00e9t\u00e9 identifi\u00e9s.<\/p>\n\n\n\n

*#ash24 OR #ash2024 OR #ASHTrainee OR #ASHkudos OR #ASHRunWalk OR #ASHaiku<\/p>\n\n\n\n

M\u00e9thodologie<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Volume des conversations<\/h2>\n\n\n\n

Le pic des conversations a eu lieu pendant la conf\u00e9rence, repr\u00e9sentant 72% des mentions enregistr\u00e9es pendant la p\u00e9riode d'\u00e9coute.<\/p>\n\n\n\n

Volume de mentions sur les heures suppl\u00e9mentaires ASH 2024 : HCPs<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Top hashtags<\/h2>\n\n\n\n

Le hashtag le plus populaire \u00e9tait #mmsm (multiple myeloma social media), ce qui montre que le d\u00e9veloppement autour du my\u00e9lome multiple a b\u00e9n\u00e9fici\u00e9 de la plus grande exposition. .<\/p>\n\n\n\n

Le hashtag officiel #ash24 a \u00e9t\u00e9 sans surprise le plus utilis\u00e9. Il convient de noter l'utilisation du hashtag #imfash2024 (International Myeloma Foundation ASH 2024), qui t\u00e9moigne de l'augmentation de l'exposition au my\u00e9lome multiple cette ann\u00e9e.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Part de voix (SOV) des pathologies les plus discut\u00e9es (# de mentions) : le my\u00e9lome multiple, le lymphome \u00e0 cellules du manteau et la leuc\u00e9mie lymphocytaire chronique ont domin\u00e9 les discussions en ligne.<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Focus sur le my\u00e9lome multiple : le daratumumab ouvre de nouvelles perspectives pour les patients atteints de my\u00e9lome multiple \u00e0 haut risque.<\/h2>\n\n\n\n

L'\u00e9tude AQUILA a \u00e9t\u00e9 de loin l'essai clinique le plus discut\u00e9 dans le domaine du my\u00e9lome multiple.<\/p>\n\n\n\n

La partie de l'\u00e9tude pr\u00e9sent\u00e9e \u00e0 l'ASH s'est concentr\u00e9e sur le my\u00e9lome multiple en phase d'incubation et a \u00e9valu\u00e9 si le daratumumab fournissait des r\u00e9sultats sup\u00e9rieurs \u00e0 la norme de soins actuelle.<\/p>\n\n\n\n

Sujets de discussion (type de traitement)<\/h3>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

Volume des mentions<\/h3>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Essais cliniques les plus mentionn\u00e9s<\/h3>\n\n\n\n
\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

The ASH Annual Meeting & Exposition 2024 took place from December 7th to 10th, 2024, in San Diego, USA. This year\u2019s event was primarily an in-person event with virtual broadcasts available. With this social media analysis, we will be assessing the impact of the congress online. Scope The scope of the analysis is focused on […]<\/p>\n","protected":false},"author":4,"featured_media":7475,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"Explore the online impact of ASH 2024, with 10K HCP mentions, top hashtags, and key insights on multiple myeloma and leading clinical trials.","_seopress_robots_index":"","content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":{"0":"post-1","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-views"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/1","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/comments?post=1"}],"version-history":[{"count":0,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/posts\/1\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media\/7475"}],"wp:attachment":[{"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/media?parent=1"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/categories?post=1"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aplusaresearch.com\/fr\/wp-json\/wp\/v2\/tags?post=1"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}